Skip to main content
Clinical Trials/NCT03821298
NCT03821298UnknownNot Applicable

Psychosocial Factors a Prognostic Study of Pain Persistence in Patients With Thumb Carpometacarpal Osteoarthritis

Gannon University1 site in 1 country50 target enrollmentStarted: April 1, 2019Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Change from baseline to 12 months Visual Analog Scale (VAS)

Study Overview

Brief Summary

In this clinical trial, females with a diagnosis of thumb CMC OA, will be recruited. The primary outcome of potential risk factors of osteoarthritis, pain and function will be measured using the demographic data, visual analog scale (VAS) and Disabilities of the Arm, Shoulder and Hand (QuickDASH). Secondary out-comes will include the Pain Self-Efficacy Questionnaire (PSEQ), Tampa Scale of Kinesiophobia (TSK), Fear Avoidance Beliefs Questionnaire (FABQ), Hospital Anxiety and Depression Scale (HADS) and Impairment and Functioning Inventory (IFI). Measurements will be taken at the baseline, three, six and 12 months follow up.

Detailed Description

The study will start recruitment in April 2019.In this clinical trial, 50-100 females, aged 50 to 90 years of age, with a diagnosis of thumb CMC OA, will be recruited. The primary outcome of potential risk factors of osteoarthritis, pain and function will be measured using the demographic data, visual analog scale (VAS) and Disabilities of the Arm, Shoulder and Hand (QuickDASH). Secondary out-comes will include the Pain Self-Efficacy Questionnaire (PSEQ), Tampa Scale of Kinesiophobia (TSK), Fear Avoidance Beliefs Questionnaire (FABQ), Hospital Anxiety and Depression Scale (HADS) and Impairment and Functioning Inventory (IFI). Measurements will be tak-en at the baseline, three, six and 12 months follow up.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 90 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •women older than 18 years
  • •diagnosed with bilateral thumb CMC OA
  • •a reported pain intensity during activities of daily living (ADLs) of up to 4 of 10 on the visual analog scale (VAS)
  • •The referring hand surgeon will made the diagnosis of CMC OA based on radiographs and clinical exploration.

Exclusion Criteria

  • •neurologic disorder affecting the upper limb
  • •had received previous treatment for their hand problem in the last 6 months including an intra-articular joint injection to wrist, fingers, or thumb
  • •had fractures or a significant hand injury or previous surgery to the wrist or hand
  • •had hand or finger tenosynovitis and/or Dupuytren disease
  • •patients who did not complete any questionnaire or if they did not sign the informed consent.

Arms & Interventions

Standard of Care

Experimental

short thumb orthoses during ADL, joint reeducation for hand used, radial nerve gliding exercises and thumb proprioception exercises

Intervention: Standard of Care Hand Therapy (Other)

Outcomes

Primary Outcomes

Change from baseline to 12 months Visual Analog Scale (VAS)

Time Frame: baseline, three, six and 12 months follow up

Pain scale VAS; 0: no pain, 100: maximum pain

Change from baseline to 12 months Quick Disabilities of the Arm, Shoulder and Hand

Time Frame: baseline, three, six and 12 months follow up

Self Report Function,QuickDash scores range from 0 to 100, higher scores means more dysfunction

Secondary Outcomes

  • Change from baseline to 12 months using the Pain Self-Efficacy Questionnaire(baseline, three, six and 12 months follow up)
  • Change from baseline to 12 months using the Tampa Scale of Kinesiophobia(baseline, three, six and 12 months follow up)
  • Change from baseline to 12 months using the Fear Avoidance Beliefs Questionnaire(baseline, three, six and 12 months follow up)
  • Change from baseline to 12 months using the Hospital Anxiety and Depression Scale(baseline, three, six and 12 months follow up)
  • Change in from baseline to 12 months using the Impairment and Functioning Inventory(baseline, three, six and 12 months follow up)

Investigators

Sponsor
Gannon University
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kristin Valdes

Assistant Professor of Occupational Therapy

Gannon University

Study Sites (1)

Loading locations...

Similar Trials